News: June 2012
Bone Care International Receives Favorable Decision in Patent Infringement Matter
June 29, 2012
Analysis Group client Bone Care International, LLC, a subsidiary of Genzyme Corporation, received a favorable decision in a patent infringement matter involving Hectorol, a drug used to control hormone production in patients with kidney disease.
Managing Principal Jeffrey Kinrich Evaluates Risk Inclusion in Measuring Economic Damages
June 29, 2012
In the article, “Risk and Economic Damages: Theoretical and Practical Issues,” featured in the latest issue of Dunn on Damages, Jeffrey Kinrich and co-author Brian Brinig assess the two alternative approaches typically employed to integrate risk into a present value analysis of economic damages: the “risk-adjusted discount rate” approach and the “risk-adjusted cash flow” approach.
Consultants’ Findings on the Use of Warfarin Appear in “Current Orthopaedic Practice”
June 28, 2012
Current Orthopaedic Practice (May/June 2012) has published the results of a study by Managing Principal Mei Sheng Duh, Vice President David N. Mishol, Manager Sara Eapen, and other contributors on the problems associated with the use of the anticoagulant warfarin among patients undergoing total hip or knee replacement surgery.
Analysis Group Researchers’ Study on Venous Thromboembolism Published in “Journal of Managed Care Pharmacy”
June 27, 2012
The Journal of Managed Care Pharmacy recently published an article on the economic impacts of venous thromboembolism (VTE) coauthored by professionals from Analysis Group’s Health Care Consulting practice and researchers from the University of Illinois at Chicago, Janssen Scientific Affairs LLC, and Henry Ford Hospital.
Managing Principal Tasneem Chipty Participates in ABA Panel on Price Discrimination
June 25, 2012
In a panel discussion hosted by the American Bar Association’s (ABA) Pricing Conduct Committee at their Annual Spring Meeting, Managing Principal Tasneem Chipty joined other experts in examining the role of price discrimination in assessing the likely impact of a merger.
Outcomes Researchers’ Posters Receive Awards at ISPOR 2012
June 22, 2012
Posters presented by members of Analysis Group's Health Care Consulting practice at this year’s meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) were awarded finalist ribbons.
Analysis Group Researchers Invited to Present at Pharmacoepidemiology Conference
June 21, 2012
Researchers from Analysis Group’s Health Care Consulting practice have been invited to present at the 28th International Conference on Pharmacoepidemiology, convening Aug. 23 to 26 in Barcelona, Spain.
Affiliate Joshua Lerner Releases New EU-Focused Cloud Computing Research
June 18, 2012
Analysis Group affiliate and Harvard Business School Professor Joshua Lerner has released a white paper analyzing the effects of copyright decisions in the European Union on venture capital investment.
Vice President Arindam Ghosh Discusses the Economics of Obesity at Bariatric Surgeons’ Conference
June 13, 2012
In the plenary session “Obesity Epidemic in Canada,” Dr. Ghosh and other panelists explored a range of topics associated with obesity and related diseases.
Managing Principal Sue Tierney Explores Rollout of Air Toxics Standard
June 12, 2012
A new research report examines the impact that the implementation of the U.S. Environmental Protection Agency’s Mercury and Air Toxic Standard could have on the reliability of the nation’s electricity services.
For press inquiries or more information about Analysis Group, please contact Eileen Harrington, VP, Marketing:
617 425 8193
617 425 8001 fax
WHAT'S NEW @ ANALYSIS GROUP NEWSLETTER
The latest news on cases, affiliates, and professional staff.